Literature DB >> 12934766

Power thrombectomy in acute ischemic coronary syndromes.

On Topaz1, Emerson C Perin, Robert L Jesse, Pramod K Mohanty, Marc Carr, Uri Rosenschein.   

Abstract

Intracoronary thrombi are commonly found in patients with acute coronary syndromes. A large thrombus burden or a platelet-rich thrombus frequently resists pharmacologic therapy ("thrombolytic ceiling"). In such cases restoration of adequate antegrade coronary flow necessitates application of a mechanical force. Power thrombectomy is a revascularization strategy incorporating a mechanical device for removal of occlusive coronary thrombi in conjunction with or following administration of either platelet glycoprotein IIb/IIIa receptor inhibitors or thrombolytic agents, or both. Mechanical devices for power thrombectomy include ultrasound sonication, rheolytic thrombectomy (Angiojet), laser, transluminal extraction catheter, aspiration catheter, and to a limited extent, balloon angioplasty. In acute coronary syndromes the strategy of power thrombectomy aims to achieve the clinical advantages of more nearly complete vessel patency, improved antegrade flow, and enhanced preservation of myocardial tissue.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934766     DOI: 10.1177/000331970305400410

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  2 in total

1.  Impact of small diameter and low level of emission laser coronary atherectomy in patients with acute myocardial infarction.

Authors:  Ryo Masuda; Takashi Shibui; Yoshiaki Mizunuma; Shogo Yoshikawa; Kosuke Takeda; Hirofumi Kujiraoka; Koichiro Yamaoka; Tomoyuki Arai; Dai Inagaki; Takashi Kimura; Kiyotaka Yoshida; Masao Takahashi; Takeshi Kitamura; Rintaro Hojo; Takaaki Tsuchiyama; Seiji Fukamizu; Tetsuo Sasano
Journal:  Lasers Med Sci       Date:  2021-08-26       Impact factor: 3.161

Review 2.  Perspectives on the role of ultrasonic devices in thrombolysis.

Authors:  Shaul Atar; Uri Rosenschein
Journal:  J Thromb Thrombolysis       Date:  2004-04       Impact factor: 2.300

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.